Dan Theodorescu, MD, PhD recruited as new Director of Cedars Sinai Cancer Center
After conducting a national executive search, Cedars Sinai Medical Center has successfully recruited a new Director of the Samuel Oschin Cancer Institute in Dan Theodorescu, MD, PhD. Dr. Theodorescu will join Cedars Sinai effective July 1, 2018. He comes to Cedars Sinai after a successful stint serving as the Director of the University of Colorado Comprehensive Cancer Center, where he’s appointed as a Distinguished Professor of Surgery-Urology & Pharmacology. Dr. Theodorescu is an internationally renowned cancer leader and physician scientist that also serves as the Co-Editor in Chief, Bladder Cancer.
Dr. Theodorescu replaces Dr. Steven Piantadosi, who stepped down in August to head a Cedars-Sinai research center before announcing a pending move to Harvard Medical School. The cancer institute has since been run by Interim Director Dr. Howard M. Sandler.
Theodorescu, a native of Romania who grew up in Canada, is considered a nationally recognized cancer researcher who has made major cancer therapeutic discoveries.
During his eight years at the University of Colorado, the professor of surgery and pharmacology oversaw the only National Cancer Institute-designated cancer center in the state. In the lab, he is known for work on molecular mechanisms underlying bladder cancer and turning them into medical treatments.
He has published more than 300 journal articles and is founding co-editor of Bladder Cancer, the first journal of its kind. At Cedars-Sinai, Theodorescu will manage a complex and growing integrated cancer program, according to the hospital. He brings a vision for cancer care that employs precision medicine, “big data,” and population health research.
ABOUT CEDARS SINAI
Cedars-Sinai is a nonprofit academic healthcare organization serving the diverse Los Angeles community and beyond. With pioneering medical research achievements, education programs defining the future of healthcare, and wide-ranging community benefit activities, we’re setting new standards for quality and innovation in patient care.
ABOUT CEDARS SINAI’S SAMUEL OSCHIN CANCER CENTER
The center, nationally ranked by U.S. News & World Report, treats more than 60 types of cancer. Its team of experts works to build a treatment plan to meet each patient’s specific needs. The center’s outpatient infusion center offers chemotherapy and supportive services. The infusion center is open 24 hours a day, seven days a week and offers 18 private rooms for treatment sessions six hours or longer.
CREDITS: https://labusinessjournal.com/news/2018/may/24/cedars-sinai-names-new-head-samuel-oschin-cancer-i/